Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.
OBJECTIVES To evaluate 6-month effectiveness and long-term drug-retention rates of biologic disease-modifying antirheumatic drugs (bDMARDs) in psoriatic arthritis (PsA) using real-world data analysed within an emulated multicentre clinical trial framework. Secondary objectives included the characterisation of response...